Tenax Therapeutics Inc. (TENX) has garnered attention due to recent corporate and clinical developments that underscore advancements in its late-stage pipeline.
The company is advancing levosimendan, a first-in-class K-ATP channel activator and calcium sensitizer, for the treatment of pulmonary hypertension associated with heart failure with preserved ejection fraction (PH-HFpEF). This condition remains a significant unmet medical need, with no approved therapies currently available.
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.